{"id":7778,"date":"2018-11-17T07:31:05","date_gmt":"2018-11-17T12:31:05","guid":{"rendered":"https:\/\/themedicalxchange.com\/?p=7778"},"modified":"2022-11-17T10:20:47","modified_gmt":"2022-11-17T15:20:47","slug":"aao_7019_treatment-options-on-the-horizon-for-glaucoma-management","status":"publish","type":"post","link":"https:\/\/themedicalxchange.com\/en\/2018\/11\/17\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\/","title":{"rendered":"Treatment Options on the Horizon for Glaucoma Management"},"content":{"rendered":"<h2>Addressing Poor Patient Adherence to Therapy<\/h2>\n<p>Statistics from one US study found close to one half of patients who had filled a glaucoma prescription discontinued medical therapy within six months and just slightly more than one-third (37%) had refilled their initial medication at three years after the first prescription was dispensed (Nordstrom BL et al. <em>Am J Ophthalmol<\/em>. 2005;140:598-606). Of note, patients with diagnosed open angle glaucoma were more likely to adhere to treatment than those with suspected glaucoma. Further, although the study showed differences in adherence among the four drug classes tested, these results indicate that there is indeed room for improvement.<\/p>\n<p>At this year\u2019s American Academy of Ophthalmology (AAO) scientific meeting during the Glaucoma Subspecialty Day sessions, Dr. James D. Brandt, Professor of Ophthalmology and Vision Science and the Director of the Glaucoma Service at the University of California, Davis, California, presented some examples of devices under study that may offer alternative options in controlling IOP.\u00a0<\/p>\n<p>\u201cWe have a significant treatment paradox,\u201d said Dr. Brandt. \u201cWe have highly-effective treatments that work [eye drops], but we know as many as 50% of our patients do not take their drops. Also, we are very poor at identifying patients who are compliant and those who are not. Sustained-release delivery will help us address this challenge. It has the potential for long-term IOP control without daily dosing\u201d \u00a0<a href=\"javascript:void(0)\" class=\"show-image\" data-index=\"0\">(Fig. 1<\/a>).<\/p>\n<h2>IOP Home Monitoring<\/h2>\n<p>Home monitoring of IOP will be a necessary component in glaucoma care should sustained-release therapies become available, according to Dr. Brandt. \u201cAn integral part of the acceptance of sustained-release [therapies] is going to be home tonometry,\u201d he said, noting symptoms do not occur that indicate to patients that they are experiencing IOP elevation and require treatment.<\/p>\n<p>\u201cRight now, we just get snapshots of IOP in the clinic,\u201d according to Dr. Patrick Gooi, Glaucoma Subsection Lead, University of Calgary, Alberta. \u201cIOP fluctuates over the course of 24 hours. Data management with home tonometry will be important so that we can get reliable data and transfer the data in a secure and meaningful way to physicians.\u201d\u00a0<\/p>\n<blockquote>\n<p>\u201cIf you see that IOP is fluctuating more than the clinical visits suggest, that may lead toward escalating therapy, with drops, laser, or surgery.\u201d<\/p>\n<\/blockquote>\n<p>The data that home tonometry technologies would generate could inform therapeutic choices. \u201cIf you see that IOP is fluctuating more than the clinical visits suggest, that may lead toward escalating therapy, with drops, laser, or surgery,\u201d said Dr. Gooi.<\/p>\n<h2>Conclusion<\/h2>\n<p>More treatment options and improved IOP monitoring may allow clinicians to make more informed, individualized management plans for glaucoma patients.<\/p>\n","protected":false},"excerpt":{"rendered":"<p><b> Chicago<\/b> \u2013 Adherence to medical therapy among glaucoma patients is less than optimal. To respond to this challenge, investigators are exploring alternative strategies for delivering medical therapies. To make these sustained-release platforms viable, at-home intraocular pressure (IOP) monitoring will likely become an element in overall glaucoma management.<\/p>\n","protected":false},"author":9,"featured_media":7780,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"tags":[473,485,481,486],"class_list":["post-7778","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-473","tag-aao","tag-extract","tag-ophthalmology","area_tag-ophthalmology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Treatment Options on the Horizon for Glaucoma Management - The Medical Xchange<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/themedicalxchange.com\/en\/2018\/11\/17\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Treatment Options on the Horizon for Glaucoma Management - The Medical Xchange\" \/>\n<meta property=\"og:description\" content=\"Chicago \u2013 Adherence to medical therapy among glaucoma patients is less than optimal. To respond to this challenge, investigators are exploring alternative strategies for delivering medical therapies. To make these sustained-release platforms viable, at-home intraocular pressure (IOP) monitoring will likely become an element in overall glaucoma management.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/themedicalxchange.com\/en\/2018\/11\/17\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\/\" \/>\n<meta property=\"og:site_name\" content=\"The Medical Xchange\" \/>\n<meta property=\"article:published_time\" content=\"2018-11-17T12:31:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-11-17T15:20:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2018\/11\/AAO_2018_glaucoma_7019_Fig1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"960\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Daniela Lopes\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Daniela Lopes\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2018\\\/11\\\/17\\\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2018\\\/11\\\/17\\\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\\\/\"},\"author\":{\"name\":\"Daniela Lopes\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#\\\/schema\\\/person\\\/f3318b53ccceaeb046bcb26e99f5c94c\"},\"headline\":\"Treatment Options on the Horizon for Glaucoma Management\",\"datePublished\":\"2018-11-17T12:31:05+00:00\",\"dateModified\":\"2022-11-17T15:20:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2018\\\/11\\\/17\\\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\\\/\"},\"wordCount\":436,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2018\\\/11\\\/17\\\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/AAO_2018_glaucoma_7019_Fig1.png\",\"keywords\":[\"2018\",\"AAO\",\"extract\",\"ophthalmology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2018\\\/11\\\/17\\\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\\\/\",\"url\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2018\\\/11\\\/17\\\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\\\/\",\"name\":\"Treatment Options on the Horizon for Glaucoma Management - The Medical Xchange\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2018\\\/11\\\/17\\\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2018\\\/11\\\/17\\\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/AAO_2018_glaucoma_7019_Fig1.png\",\"datePublished\":\"2018-11-17T12:31:05+00:00\",\"dateModified\":\"2022-11-17T15:20:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#\\\/schema\\\/person\\\/f3318b53ccceaeb046bcb26e99f5c94c\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2018\\\/11\\\/17\\\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2018\\\/11\\\/17\\\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2018\\\/11\\\/17\\\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\\\/#primaryimage\",\"url\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/AAO_2018_glaucoma_7019_Fig1.png\",\"contentUrl\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/AAO_2018_glaucoma_7019_Fig1.png\",\"width\":960,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/2018\\\/11\\\/17\\\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Treatment Options on the Horizon for Glaucoma Management\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/\",\"name\":\"The Medical Xchange\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#\\\/schema\\\/person\\\/f3318b53ccceaeb046bcb26e99f5c94c\",\"name\":\"Daniela Lopes\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a4d4340f72c70805b8fc092df1dd86431200950aa59bad0988855570fdf53af5?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a4d4340f72c70805b8fc092df1dd86431200950aa59bad0988855570fdf53af5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a4d4340f72c70805b8fc092df1dd86431200950aa59bad0988855570fdf53af5?s=96&d=mm&r=g\",\"caption\":\"Daniela Lopes\"},\"url\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/author\\\/daniela\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Treatment Options on the Horizon for Glaucoma Management - The Medical Xchange","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/themedicalxchange.com\/en\/2018\/11\/17\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\/","og_locale":"en_US","og_type":"article","og_title":"Treatment Options on the Horizon for Glaucoma Management - The Medical Xchange","og_description":"Chicago \u2013 Adherence to medical therapy among glaucoma patients is less than optimal. To respond to this challenge, investigators are exploring alternative strategies for delivering medical therapies. To make these sustained-release platforms viable, at-home intraocular pressure (IOP) monitoring will likely become an element in overall glaucoma management.","og_url":"https:\/\/themedicalxchange.com\/en\/2018\/11\/17\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\/","og_site_name":"The Medical Xchange","article_published_time":"2018-11-17T12:31:05+00:00","article_modified_time":"2022-11-17T15:20:47+00:00","og_image":[{"width":960,"height":720,"url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2018\/11\/AAO_2018_glaucoma_7019_Fig1.png","type":"image\/png"}],"author":"Daniela Lopes","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Daniela Lopes","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/themedicalxchange.com\/en\/2018\/11\/17\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\/#article","isPartOf":{"@id":"https:\/\/themedicalxchange.com\/en\/2018\/11\/17\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\/"},"author":{"name":"Daniela Lopes","@id":"https:\/\/themedicalxchange.com\/en\/#\/schema\/person\/f3318b53ccceaeb046bcb26e99f5c94c"},"headline":"Treatment Options on the Horizon for Glaucoma Management","datePublished":"2018-11-17T12:31:05+00:00","dateModified":"2022-11-17T15:20:47+00:00","mainEntityOfPage":{"@id":"https:\/\/themedicalxchange.com\/en\/2018\/11\/17\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\/"},"wordCount":436,"commentCount":0,"image":{"@id":"https:\/\/themedicalxchange.com\/en\/2018\/11\/17\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\/#primaryimage"},"thumbnailUrl":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2018\/11\/AAO_2018_glaucoma_7019_Fig1.png","keywords":["2018","AAO","extract","ophthalmology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/themedicalxchange.com\/en\/2018\/11\/17\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\/","url":"https:\/\/themedicalxchange.com\/en\/2018\/11\/17\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\/","name":"Treatment Options on the Horizon for Glaucoma Management - The Medical Xchange","isPartOf":{"@id":"https:\/\/themedicalxchange.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/themedicalxchange.com\/en\/2018\/11\/17\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\/#primaryimage"},"image":{"@id":"https:\/\/themedicalxchange.com\/en\/2018\/11\/17\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\/#primaryimage"},"thumbnailUrl":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2018\/11\/AAO_2018_glaucoma_7019_Fig1.png","datePublished":"2018-11-17T12:31:05+00:00","dateModified":"2022-11-17T15:20:47+00:00","author":{"@id":"https:\/\/themedicalxchange.com\/en\/#\/schema\/person\/f3318b53ccceaeb046bcb26e99f5c94c"},"breadcrumb":{"@id":"https:\/\/themedicalxchange.com\/en\/2018\/11\/17\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/themedicalxchange.com\/en\/2018\/11\/17\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/themedicalxchange.com\/en\/2018\/11\/17\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\/#primaryimage","url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2018\/11\/AAO_2018_glaucoma_7019_Fig1.png","contentUrl":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2018\/11\/AAO_2018_glaucoma_7019_Fig1.png","width":960,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/themedicalxchange.com\/en\/2018\/11\/17\/aao_7019_treatment-options-on-the-horizon-for-glaucoma-management\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/themedicalxchange.com\/en\/"},{"@type":"ListItem","position":2,"name":"Treatment Options on the Horizon for Glaucoma Management"}]},{"@type":"WebSite","@id":"https:\/\/themedicalxchange.com\/en\/#website","url":"https:\/\/themedicalxchange.com\/en\/","name":"The Medical Xchange","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/themedicalxchange.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/themedicalxchange.com\/en\/#\/schema\/person\/f3318b53ccceaeb046bcb26e99f5c94c","name":"Daniela Lopes","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a4d4340f72c70805b8fc092df1dd86431200950aa59bad0988855570fdf53af5?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a4d4340f72c70805b8fc092df1dd86431200950aa59bad0988855570fdf53af5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a4d4340f72c70805b8fc092df1dd86431200950aa59bad0988855570fdf53af5?s=96&d=mm&r=g","caption":"Daniela Lopes"},"url":"https:\/\/themedicalxchange.com\/en\/author\/daniela\/"}]}},"_links":{"self":[{"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/posts\/7778","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/comments?post=7778"}],"version-history":[{"count":0,"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/posts\/7778\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/media\/7780"}],"wp:attachment":[{"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/media?parent=7778"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/themedicalxchange.com\/en\/wp-json\/wp\/v2\/tags?post=7778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}